Physician profile
Christopher Needham
NPI 1942720628
$6,876.04
in general payments reported to CMS, 2019-2025
18 companies · $1,320 in 2025
The $1,320 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $248 · 2021: $1,132 · 2022: $1,256 · 2023: $1,159 · 2024: $1,265 · 2025: $1,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,744.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,649.69 | 2021-2025 | Total30, Precision7, Precision 1 |
| Bausch & Lomb Americas INC. | $1,105.43 | 2022-2025 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $960.16 | 2021-2025 | Acuvue |
| Biotissue Holdings INC. | $452.72 | 2020-2025 | |
| Kala Pharmaceuticals, INC. | $428.64 | 2020-2022 | |
| Sight Sciences, INC. | $398.81 | 2019-2023 | Omni Surgical System |
| Abbvie INC. | $295.87 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $277.46 | 2019-2021 | |
| Oyster Point Pharma, INC. | $239.55 | 2023 | Tyrvaya |
| Allergan, INC. | $236.82 | 2019-2022 | |
| Shire North American Group INC | $228.18 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $197.16 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $122.40 | 2025 | Idosetr |
| Sun Pharmaceutical Industries INC. | $118.71 | 2019-2020 | |
| Coopervision INC. | $56.52 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $51.59 | 2020-2021 | |
| Optos, INC. | $45.12 | 2019 | |
| Alcon Research LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Needham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.